Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models

Nature Neuroscience

Volumn 15, Issue 6, 2012, Pages 862-870

  Bai, Lianhua ^a   Lennon, Donald P ^b   Caplan, Arnold I ^b   Dechant, Anne ^a   Hecker, Jordan ^a   Kranso, Janet ^a   Zaremba, Anita ^a   Miller, Robert H ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYSOPHOSPHATIDYLCHOLINE; MEMBRANE RECEPTOR; MEMBRANE RECEPTOR CMET; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; SCATTER FACTOR; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MOUSE; MULTIPLE SCLEROSIS; NERVE CELL; NERVE CELL DIFFERENTIATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; REMYELINIZATION; SPINAL CORD LESION;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; NEUROGENESIS; NEURONS; OLIGODENDROGLIA; PROTO-ONCOGENE PROTEINS C-MET; RATS; RECOVERY OF FUNCTION; SPINAL CORD; STEM CELLS;

EID: 84861574208     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.3109     Document Type: Article

References (50)

1. Prineas, J.W. The neuropathology of multiple sclerosis. in Handbook of Clinical Neurology (ed. Koestier, J.C.) 15-30 (Elsevier, Amsterdam, 1985).
2. Trapp, B.D. et al. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338, 278-285 (1998).
3. Wolswijk, G. & Noble, M. Identification of an adult-specific glial progenitor cell. Development 105, 387-400 (1989).
4. Reynolds, B.A. & Weiss, S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255, 1707-1710 (1992).
5. Ben-Hur, T. & Goldman, S.A. Prospects of cell therapy for disorders of myelin. Ann. NY Acad. Sci. 1142, 218-249 (2008).
6. Uccelli, A., Pistoia, V. & Moretta, L. Mesenchymal stem cells: a new strategy for immunosuppression? Trends Immunol. 28, 219-226 (2007).
7. Pluchino, S. et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 422, 688-694 (2003).
8. Busch, S.A. et al. Adult NG2+ cells are permissive to neurite outgrowth and stabilize sensory axons during macrophage-induced axonal dieback after spinal cord injury. J. Neurosci. 30, 255-265 (2010).
9. Caplan, A.I. & Dennis, J.E. Mesenchymal stem cell as trophic mediators. J. Cell Biochem. 98, 1076-1084 (2006).
10. Lazarus, H.M. et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol. Blood Marrow Transplant. 11, 389-398 (2005).
11. Yoo, S.W. et al. Mesenchymal stem cells promote proliferation of endogenous neural stem cells and survival of newborn cells in a rat stroke model. Exp. Mol. Med. 40, 387-397 (2008).
12. Jung, D.I. et al. A comparison of autologous and allogenic bone marrow-derived mesenchymal stem cell transplantation in canine spinal cord injury. J. Neurol. Sci. 285, 67-77 (2009).
13. Bai, L. et al. Human bone marrow-derived mesenchymal stem cell induce Th2 polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 57, 1192-1203 (2009).
14. Rafei, M., Birman, E., Forner, K. & Galipeau, J. Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis. Mol. Ther. 17, 1799-1803 (2009).
15. Tanaka, F. et al. Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats. Life Sci. 83, 771-779 (2008).
16. Barhum, Y. et al. Intracerebroventricular transplantation of human mesenchymal stem cells induced to secrete neurotrophic factors attenuates clinical symptoms in a mouse model of multiple sclerosis. J. Mol. Neurosci. 41, 129-137 (2010).
17. Krampera, M. et al. Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus. Bone 40, 382-390 (2007).
18. Michalopoulos, G.K. Liver regeneration: molecular mechanisms of growth control. FASEB J. 4, 176-187 (1990).
19. Achim, C.L. et al. Expression of HGF and cMet in the developing and adult brain. Brain Res. Dev. Brain Res. 102, 299-303 (1997).
20. Sulpice, E. et al. Cross-talk between the VEGF-A and HGF signalling pathways in endothelial cells. Biol. Cell 101, 525-539 (2009).
21. Kitamura, K. et al. Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury. J. Neurosci. Res. 85, 2332-2342 (2007).
22. Anan, F. et al. Predictors for silent cerebral infarction in patients with chronic renal failure undergoing hemodialysis. Metabolism 56, 593-598 (2007).
23. Deuse, T. et al. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction. Circulation 120, S247-S254 (2009).
24. Sheth, P.R., Hays, J.L., Elferink, L.A. & Watowich, S.J. Biochemical basis for the functional switch that regulates hepatocyte growth factor receptor tyrosine kinase activation. Biochemistry 47, 4028-4038 (2008).
25. Sonnenberg, E., Meyer, D., Weidner, K.M. & Birchmeier, C. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J. Cell Biol. 123, 223-235 (1993).
26. Ishiki, Y., Ohnishi, H., Muto, Y., Matsumoto, K. & Nakamura, T. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 16, 1227-1235 (1992).
27. Polisetti, N. et al. Gene expression profile of epithelial cells and mesenchymal cells derived from limbal explant culture. Mol. Vis. 16, 1227-1240 (2010).
28. Wang, Y. et al. MEK, p38, and PI-3K mediate cross talk between EGFR and TNFR in enhancing hepatocyte growth factor production from human mesenchymal stem cells. Am. J. Physiol. Cell Physiol. 297, C1284-C1293 (2009).
29. Ebens, A. et al. Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons. Neuron 17, 1157-1172 (1996).
30. Yan, H. & Rivkees, S.A. Hepatocyte growth factor stimulates the proliferation and migration of oligodendrocyte precursor cells. J. Neurosci. Res. 69, 597-606 (2002).
31. Bottaro, D.P. et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251, 802-804 (1991).
32. Sun, W., Funakoshi, H. & Nakamura, T. Localization and functional role of hepatocyte growth factor (HGF) and its receptor c-met in the rat developing cerebral cortex. Brain Res. Mol. Brain Res. 103, 36-48 (2002).
33. van der Horst, E.H. et al. Discovery of fully human anti-MET monoclonal antibodies with antitumor activity against colon cancer tumor models in vivo. Neoplasia 11, 355-364 (2009).
34. Bai, L., Caplan, A., Lennon, D. & Miller, R.H. Mesenchymal stem cell signals regulate neural stem cell fate. Neurochem. Res. 32, 353-362 (2007).
35. Gerdoni, E. et al. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann. Neurol. 61, 219-227 (2007).
36. Siatskas, C., Payne, N.L., Short, M.A. & Bernard, C.C. A consensus statement addressing mesenchymal stem cell transplantation for multiple sclerosis: it′s time!. Stem Cell Rev. 4, 500-506 (2010).
37. Birchmeier, C. & Gherardi, E. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol. 8, 404-410 (1998).
38. Koç, O.N. et al. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant. 30, 215-222 (2002).
39. Kuroiwa, T. et al. Hepatocyte growth factor ameliorates acute graft-versus-host disease and promotes hematopoietic function. J. Clin. Invest. 107, 1365-1373 (2001).
40. Futamatsu, H. et al. Hepatocyte growth factor ameliorates the progression of experimental autoimmune myocarditis: a potential role for induction of T helper 2 cytokines. Circ. Res. 96, 823-830 (2005).
41. Benkhoucha, M. et al. Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 107, 6424-6429 (2010).
42. Karussis, D. & Kassis, I. The potential use of stem cells in multiple sclerosis: an overview of the preclinical experience. Clin. Neurol. Neurosurg. 110, 889-896 (2008).
43. Di Renzo, M.F. et al. Selective expression of the Met/HGF receptor in human central nervous system microglia. Oncogene 8, 219-222 (1993).
44. Ghasemlou, N., Jeong, S.Y., Lacroix, S. & David, S. T cells contribute to lysophosphatidylcholine-induced macrophage activation and demyelination in the CNS. Glia 55, 294-302 (2007).
45. Franklin, R.J. & Ffrench-Constant, C. Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 9, 839-855 (2008).
46. Pan, W. et al. Permeation of hepatocyte growth factor across the blood-brain barrier. Exp. Neurol. 201, 99-104 (2006).
47. Miller, R.H. & Fyffe-Maricich, S.L. Restoring the balance between disease and repair in multiple sclerosis: insights from mouse models. Dis. Model. Mech. 3, 535-539 (2010).
48. Hayashi, S. et al. Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells. Biochem. Biophys. Res. Commun. 220, 539-545 (1996).
49. Kerstetter, A.E., Padovani-Claudio, D.A., Bai, L. & Miller, R.H. Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis. Exp. Neurol. 220, 44-56 (2009).
50. Lennon, D.P. & Caplan, A.I. Isolation of human marrow-derived mesenchymal stem cells. Exp. Hematol. 34, 1604-1605 (2006).